Albemarle CorporationALBNYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
1.85%
↑ 321% above average
Average (39q)
-0.84%
Historical baseline
Range
High:32.64%
Low:-29.58%
CAGR
+0.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 1.85% |
| Q2 2025 | -11.74% |
| Q1 2025 | -29.58% |
| Q4 2024 | -10.61% |
| Q3 2024 | 7.83% |
| Q2 2024 | -11.74% |
| Q1 2024 | 3.42% |
| Q4 2023 | 7.93% |
| Q3 2023 | -1.57% |
| Q2 2023 | 4.63% |
| Q1 2023 | 1.57% |
| Q4 2022 | 9.78% |
| Q3 2022 | 5.59% |
| Q2 2022 | 8.10% |
| Q1 2022 | 32.64% |
| Q4 2021 | -8.76% |
| Q3 2021 | -4.92% |
| Q2 2021 | -4.51% |
| Q1 2021 | -4.81% |
| Q4 2020 | 13.62% |
| Q3 2020 | -4.77% |
| Q2 2020 | -11.72% |
| Q1 2020 | 12.86% |
| Q4 2019 | -8.48% |
| Q3 2019 | 15.77% |
| Q2 2019 | -10.12% |
| Q1 2019 | -8.59% |
| Q4 2018 | -1.36% |
| Q3 2018 | 3.33% |
| Q2 2018 | -23.41% |
| Q1 2018 | 0.38% |
| Q4 2017 | -3.93% |
| Q3 2017 | 25.53% |
| Q2 2017 | -28.72% |
| Q1 2017 | 27.41% |
| Q4 2016 | -9.14% |
| Q3 2016 | 2.50% |
| Q2 2016 | -12.40% |
| Q1 2016 | -9.12% |
| Q4 2015 | 1.79% |